Second Generation DICART Prototype Validation

NCT ID: NCT05847998

Last Updated: 2025-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-06

Study Completion Date

2023-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Capillary refill time (CRT) is a clinical sign for diagnosis of acute circulatory failure and response to treatment but is also associated with prognosis in patient with shock.

CRT is clinically evaluated by physician with a high risk of inter and intra evaluator variations, depending, for example, on measurement site, pressure applicated or visual evaluation.

The investigator hypothesizes that CRT measurement with second generation DICART prototype will be well correlated with clinical measurement.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Circulatory Failure Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

measurement of capillary refill time

measurement in a cohort of ICU adult patients with acute circulatory failure

Group Type EXPERIMENTAL

Standardized measurement of capillary refill time by second generation DICART prototype

Intervention Type DEVICE

Capillary refill time is measured by two independent operators, each one blinded from the other, with second generation DICART prototype.

Each operator performs two series of three consecutive measurement on the finger.

Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax

Clinical measurement of capillary refill time

Intervention Type DIAGNOSTIC_TEST

Capillary refill time is clinically measured by two independent operators, each one blinded from the other.

Each operator performs, two series of three consecutive measurement on the second finger.

Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax, inverted relative to DICART measurements.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standardized measurement of capillary refill time by second generation DICART prototype

Capillary refill time is measured by two independent operators, each one blinded from the other, with second generation DICART prototype.

Each operator performs two series of three consecutive measurement on the finger.

Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax

Intervention Type DEVICE

Clinical measurement of capillary refill time

Capillary refill time is clinically measured by two independent operators, each one blinded from the other.

Each operator performs, two series of three consecutive measurement on the second finger.

Then, an operator performs a train of three measurements on the knee, and the other operator on the thorax, inverted relative to DICART measurements.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-\>18 years old

* Acute circulatory failure
* Written informed consent given by patient or its relatives

Exclusion Criteria

* Pregnant women, breastfeeding women, childbearing age women without oral contraception
* Cutaneous lesion at measurement site
* Patient under legal protection
* Patient already included in another interventional clinical trial
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthias JACQUET-LAGREZE, MD, PHD

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Louis Pradel Cardiologic Hospistal

Bron, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Descamps A, Jacquet-Lagreze M, Aussal T, Fellahi JL, Ruste M. DiCARTTM device to measure capillary refill time: a validation study in patients with acute circulatory failure. J Clin Monit Comput. 2025 Oct;39(5):831-840. doi: 10.1007/s10877-025-01271-5. Epub 2025 Feb 26.

Reference Type RESULT
PMID: 40011397 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02595-36

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL21_0635

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.